相关实验视频

Updated: Jan 17, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.9K

对新诊断多发性骨髓瘤患者的高风险基因组共识验证,使用下一代测序

Anaïs Schavgoulidze1, Aurore Perrot2, Xavier Leleu3

  • 1Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.

Blood
|September 24, 2025
PubMed
概括

国际骨髓瘤学会 (IMS) /国际骨髓瘤工作组 (IMWG) 基因组模型准确识别高风险 (HR) 多发骨髓瘤患者,显示明显较短的无进展生存期 (PFS). 这项验证支持其在临床环境中用于个性化风险评估.

更多相关视频

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.6K

相关概念视频

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.8K